The Digital Patient: The Future of Mobile Health for Respiratory Patients
The wave of digital health is continuously growing and promises to transform the experience of patients. Respiratory medicine is in the centre of these developments, as it has the potential of being benefited by all the components of the digital patient experience. Firstly, mobile health technologies will allow the quantitative measurement of clinical, behavioural and environmental factors in the real life environment, allowing the accurate monitoring of the progression and treatment of respiratory diseases. Furthermore, the creation of strong communication links between patients, their families and the healthcare personnel promises to minimise the dangers connected to exacerbations and also elevate the related social barriers. Finally, the digital patient profile is expected to allow the efficient and safe self-management of respiratory diseases by patients, using the help of smart automated systems and under the supervision of healthcare professionals. The current presentation describes an EU Horizon2020 project; myAirCoach and its innovative vision for asthma treatment. It will focus on the above three pillars of the digital patient experience, present a technical review of the available solutions and devices, and relate this in particular to the foundation of respiratory management which is the inhaled drug delivery. Based on the identified gaps, a methodology approach will be presented for the optimisation of respiratory treatment, in particular asthma management, in the digital era.
K.Votis, D. Kikidis, D. Tzovaras, O. Usmani. "The Digital Patient: The Future of Mobile Health for Respiratory Patients". In proceedings of the 2015 Congress of the International Society for Aerosols in Medicine. Munich, Germany, 30 May- 3 June 2015.
See also: Wolff, Ron K., et al. "Abstracts: International Society for Aerosols in Medicine eV 20th ISAM Congress Munich Holiday Inn-City Center, Germany May 30–June 3, 2015." Journal of Aerosol Medicine and Pulmonary Drug Delivery (2015).